The 17 members of a federal vaccine advisory committee, who were ousted last week, argued their abrupt dismissal has "left the U.S. vaccine program critically weakened." The group, speaking ...

All 17 experts recently dismissed from a government vaccine advisory panel published an essay Monday decrying “destabilizing ...

The incidence of RSV across 5 respiratory virus seasons was substantial among adult patients with high-risk underlying conditions.

Dr. Lbiati's appointment signals a new chapter for Hepion-one focused on strategic renewal, value creation, and diagnostic ...

Notable research news last week included US biopharma Avidity Biosciences announcing a positive update on its muscular ...

Albertans who want to continue to protect themselves from the COVID-19 virus will have to pay out of pocket for it starting in the fall of 2025, the province announced on Friday.

Cleveland health officials are warning residents after a 250% spike in COVID-19 viral levels was found in city wastewater.

The Food and Drug Administration (FDA) expanded the approval of Moderna’s RSV vaccine late Thursday to include people 18 to ...

RESVIA is now authorized for use in adults aged 18–59 years with an increased risk of respiratory syncytial virus-related ...

The FDA has approved Enflonsia (clesrovimab-cfor) for the prevention of RSV lower respiratory tract disease in neonates and ...

The Food and Drug Administration has approved a new drug from Merck designed to protect infants from respiratory syncytial ...

The FDA expanded the approval of Moderna’s RSV vaccine, extending the license to include more adults and giving the company a ...